Reduced Dose Direct Oral Anticoagulants Compared to Warfarin With High Time in Therapeutic Range in Nonvalvular Atrial Fibrillation

被引：0
|
作者：
Jansson, Martin
Sjogren, Vilhelm
Sjalander, Sara
Bjorck, Fredrik
Renlund, Henrik
Norrving, Bo
Sjalander, Anders
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15358
引用
收藏
页数：2
相关论文
共 50 条
  • [21] WARFARIN TIME IN THERAPEUTIC RANGE TRAJECTORIES IN POTENTIAL SWITCHERS TO DIRECT ORAL ANTICOAGULANTS
    Pundi, Krishna
    Perino, Alexander
    Fan, Jun
    Schmitt, Susan
    Kothari, Mitra
    Szummer, Karolina
    Askari, Mariam
    Heidenreich, Paul A.
    Turakhia, Mintu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 416 - 416
  • [22] New oral anticoagulants in nonvalvular atrial fibrillation
    Lega, Jean-Christophe
    Bertoletti, Laurent
    Durupt, Stephane
    Epinat, Magali
    Mismetti, Patrick
    Da Costa, Antoine
    Laporte, Silvy
    PRESSE MEDICALE, 2013, 42 (09): : 1225 - 1231
  • [23] Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study
    Lehto, M.
    Luojus, A.
    Halminen, O.
    Haukka, J.
    Lehtonen, O.
    Tiili, P.
    Aro, A. L.
    Putaala, J.
    Linna, M.
    Mustonen, P.
    Kinnunen, J.
    Niemi, M.
    Hartikainen, J.
    Airaksinen, K. E. J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [24] BLEEDING RISK OF DIRECT ORAL ANTICOAGULANTS COMPARED WITH WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND HEART FAILURE
    Lu, Lingyun
    Warner, Alberta
    Ghaznavi, Zunera
    Chang, Donald
    Tubert, Nikolas
    Jackevicius, Cynthia
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 900 - 900
  • [25] Safety and Effectiveness of Dabigatran and Other Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation
    Huybrechts, Krista F.
    Gopalakrishnan, Chandrasekar
    Bartels, Dorothee B.
    Zint, Kristina
    Gurusamy, Venkatesh K.
    Landon, Joan
    Schneeweiss, Sebastian
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (06) : 1405 - 1419
  • [26] Efficiency of the Left Atrial Appendage Thrombus Dissolution in Patients with Persistent Nonvalvular Atrial Fibrillation with Warfarin or Direct Oral Anticoagulants Therapy
    Mazur, E. S.
    Mazur, V. V.
    Bazhenov, N. D.
    Orlov, Yu A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2021, 17 (05) : 724 - 728
  • [27] Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory Data
    Boesen, Kim
    Saiz, Luis Carlos
    Gotzsche, Peter C.
    Erviti, Juan
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2025, 18 (03):
  • [28] The Dose of Direct Oral Anticoagulants and Stroke Severity in Patients with Acute Ischemic Stroke and Nonvalvular Atrial Fibrillation
    Kato, Yuji
    Hayashi, Takeshi
    Tanahashi, Norio
    Takao, Masaki
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (06): : 1490 - 1496
  • [29] ARE LOW DOSES OF DIRECT-ACTING ORAL ANTICOAGULANTS JUSTIFIED AND APPROPRIATE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION? NONVALVULAR ATRIAL FIBRILLATION?
    Martinez-Rubio, A.
    Martinez-Torrecilla, O.
    CARDIOLOGY, 2017, 137 : 159 - 159
  • [30] Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight
    Bodega, Francesca
    Russi, Anita
    Melillo, Francesco
    Blunda, Fabiana
    Rubino, Claudia
    Leo, Giulio
    Cappelletti, Alberto
    Mazzone, Patrizio
    Mattiello, Paolo
    Della Bella, Paolo
    Castiglioni, Alessandro
    Alfieri, Ottavio
    De Bonis, Michele
    Montorfano, Matteo
    Tresoldi, Moreno
    Filippi, Massimo
    Salerno, Anna
    Cera, Michela
    Zangrillo, Alberto
    Alberto, Margonato
    Godino, Cosmo
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52 (01)
12345